CPA
Cowen Prime Advisors Portfolio holdings
AUM
$290M
This Quarter Return
+26.74%
1 Year Return
+57.79%
3 Year Return
+115.61%
5 Year Return
+253.96%
10 Year Return
+968.93%
AUM
$264M
AUM Growth
+$264M
(+17%)
Cap. Flow
-$2.26M
Cap. Flow
% of AUM
-0.86%
Top 10 Holdings %
Top 10 Hldgs %
56.61%
Holding
183
New
11
Increased
36
Reduced
18
Closed
10
Top Buys
| 1 |
Standard BioTools
LAB
|
$4.44M |
| 2 |
Comscore
SCOR
|
$4.18M |
| 3 |
GTYH
GTY Technology Holdings, Inc. Common Stock
GTYH
|
$3.52M |
| 4 |
PDF Solutions
PDFS
|
$2.73M |
| 5 |
VG
Vonage Holdings Corporation
VG
|
$2.5M |
Top Sells
| 1 |
GAN
GAN Ltd
GAN
|
$8.7M |
| 2 |
GNMK
GenMark Diagnostics, Inc
GNMK
|
$7.94M |
| 3 |
QUOT
Quotient Technology Inc
QUOT
|
$6.76M |
| 4 |
INOV
Inovalon Holdings, Inc. Class A Common Stock
INOV
|
$2.3M |
| 5 |
Aspen Aerogels
ASPN
|
$1.59M |
Sector Composition
| 1 | Technology | 30.87% |
| 2 | Communication Services | 24.53% |
| 3 | Healthcare | 13.2% |
| 4 | Industrials | 9.29% |
| 5 | Financials | 3.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Pfizer
PFE
$141B
| $2.63M | 1% |
72,625
+650
| +0.9% | +$23.5K |
|
27
MACOM Technology Solutions
MTSI
$9.56B
| $2.48M | 0.94% |
42,708
+2,450
| +6% | +$142K |
|
28
Apyx Medical
APYX
$74.1M
| $2.41M | 0.91% |
248,959
+13,000
| +6% | +$126K |
|
29
Starbucks
SBUX
$99.3B
| $2.39M | 0.9% |
21,885
| – | – |
|
30
Kopin
KOPN
$335M
| $2.18M | 0.82% |
207,900
-21,500
| -9% | -$226K |
|
31
PTC
PTC
$25.2B
| $2.18M | 0.82% |
15,800
-300
| -2% | -$41.3K |
|
32
Microsoft
MSFT
$3.74T
| $2.09M | 0.79% |
8,875
| – | – |
|
33
International Flavors & Fragrances
IFF
$16.9B
| $1.93M | 0.73% |
+13,805
| New | +$1.93M |
|
34
Crown Castle
CCI
$43B
| $1.88M | 0.71% |
10,895
+3,935
| +57% | +$677K |
|
35
Enterprise Products Partners
EPD
$69.5B
| $1.63M | 0.62% |
74,080
| – | – |
|
36
Leidos
LDOS
$23.2B
| $1.59M | 0.6% |
16,520
+1,030
| +7% | +$99.2K |
|
37
Dow Inc
DOW
$17.2B
| $1.55M | 0.59% |
24,216
| – | – |
|
|
MMP
38
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $1.51M | 0.57% |
34,800
| – | – |
|
39
CEVA Inc
CEVA
$513M
| $1.44M | 0.55% |
25,656
+1,785
| +7% | +$100K |
|
40
Analog Devices
ADI
$121B
| $1.43M | 0.54% |
9,250
+750
| +9% | +$116K |
|
41
DuPont de Nemours
DD
$31.5B
| $1.38M | 0.52% |
17,849
| – | – |
|
42
Apollo Global Management
APO
$76.6B
| $1.37M | 0.52% |
29,220
+1,700
| +6% | +$79.9K |
|
|
SCTL
43
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $1.31M | 0.5% |
+470,500
| New | +$1.31M |
|
44
NeoGenomics
NEO
$1.13B
| $1.28M | 0.48% |
26,500
+1,200
| +5% | +$57.9K |
|
45
Ribbon Communications
RBBN
$715M
| $1.16M | 0.44% |
140,719
-2,800
| -2% | -$23K |
|
|
OIG
46
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
| $1.07M | 0.41% |
175,663
+16,200
| +10% | +$98.9K |
|
47
GSI Technology
GSIT
$85.2M
| $1.04M | 0.39% |
154,656
+27,300
| +21% | +$183K |
|
48
Exelon
EXC
$44.1B
| $938K | 0.35% |
21,450
+200
| +0.9% | +$8.75K |
|
49
Teva Pharmaceuticals
TEVA
$21.6B
| $938K | 0.35% |
81,294
| – | – |
|
50
Neogen
NEOG
$1.21B
| $929K | 0.35% |
10,450
| – | – |
|